Abstract
Control of human mobility is among the most effective measures to prevent the spread of coronavirus disease 2019 (COVID-19). This study aims to clarify the correlation between home range and the number of people infected with SARS-CoV-2 during the medium-term of the COVID-19 pandemic in Ibaraki City. Home ranges are analyzed by the Minimum Convex Polygon method using mobile phone GPS location history data. We analyzed the time series cross-correlation between home range lengths and the number of infected people. Results reveal a slight positive correlation between home range and the number of infected people after one week during the medium-term of the COVID-19 pandemic. Regarding home range length, the cross-correlation coefficient is 0.4030 even at a lag level of six weeks, which has the most significant coefficient. Thus, a decrease in home range is only one of the indirect factors contributing toward a reduction in the number of infected people. This study makes a significant contribution to the literature by evaluating key public health challenges from the perspective of controliing the spread of the COVID-19 infectuion. Its findings has implications for policy makers, practitioners, and urban scientists seeking to promote urban sustainability.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Funded studies H.K., 21K14318, JSPS KAKENHI, https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-21K14318/ H.K., 220201, Dai-ichi Life Foundation, http://group.dai-ichi-life.co.jp/d-housing/boshu.html T.A., 2102C, International Association of Traffic and Safety Sciences, https://www.iatss.or.jp/en/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This research protocol was approved by the ethics committee of the Graduate School of Life Science, Osaka City University (21-40).
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
GPS Location History Data cannot be shared publicly because of mobile phone users? confidentiality. Data are available from the Agoop Corpolation Institutional Data Access (contact via ESRI Japan) for researchers who meet the criteria for access to confidential data. Ibaraki City Government. Outbreaks of new coronavirus in Ibaraki city [in Japanese]. [Cited 2021 December 28]. Available from: https://www.city.ibaraki.osaka.jp/kikou/kenkoi/kenkou/menu/2covid19.html
https://www.city.ibaraki.osaka.jp/kikou/kenkoi/kenkou/menu/2covid19.html
